In a filing, Centessa Pharmaceuticals plc ADR revealed its Officer HUSSAIN IQBAL J acquired Company’s shares for reported $0.1 million on Mar 17 ’25. In the deal valued at $17.07 per share,6,000 shares were bought.
Then, CHAO DAVID M bought 7,000 shares, generating $119,490 in total proceeds.
Before that, Weinhoff Gregory M sold 11,494 shares. Centessa Pharmaceuticals plc ADR shares valued at $175,270 were divested by the Chief Business Officer at a price of $15.25 per share. As a result of the transaction, Weinhoff Gregory M now holds 134,021 shares, worth roughly $2.31 million.
TD Cowen initiated its Centessa Pharmaceuticals plc ADR [CNTA] rating to a Buy in a research note published recently. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who increased its forecast for the stock in mid September from “an Equal-weight” to “an Overweight”. B. Riley Securities began covering CNTA with “Buy” recommendation on September 19, 2024. Oppenheimer started covering the stock on July 18, 2024. It rated CNTA as “an Outperform”.
Price Performance Review of CNTA
On Monday, Centessa Pharmaceuticals plc ADR [NASDAQ:CNTA] saw its stock jump 0.35% to $17.20. Over the last five days, the stock has gained 8.86%. Centessa Pharmaceuticals plc ADR shares have risen nearly 2.69% since the year began. Nevertheless, the stocks have risen 58.53% over the past one year. While a 52-week high of $19.09 was reached on 02/07/25, a 52-week low of $7.75 was recorded on 01/14/25. SMA at 50 days reached $16.52, while 200 days put it at $14.34.
Levels Of Support And Resistance For CNTA Stock
The 24-hour chart illustrates a support level at 16.37, which if violated will result in even more drops to 15.54. On the upside, there is a resistance level at 17.85. A further resistance level may holdings at 18.50. The Relative Strength Index (RSI) on the 14-day chart is 55.14, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.76, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 22.99%. Stochastics %K at 73.13% indicates the stock is a holding.
How much short interest is there in Centessa Pharmaceuticals plc ADR?
A steep rise in short interest was recorded in Centessa Pharmaceuticals plc ADR stocks on 2025-02-28, growing by 2.41 million shares to a total of 5.46 million shares. Yahoo Finance data shows the prior-month short interest on 2025-01-31 was 3.05 million shares. There was a rise of 44.1%, which implies that there is a positive sentiment for the stock.
